US 8227417
HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants
granted A61KA61K2039/53A61K2039/55516
Quick answer
US patent 8227417 (HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K2039/53, A61K2039/55516, A61K2039/57, A61K38/1709